@article{70d7955ed72c46928451684ef2a38bde,
title = "Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism",
abstract = "Whether the oral factor Xa inhibitor edoxaban can be an alternative to warfarin in patients with venous thromboembolism is unclear.",
keywords = "Aged, Anticoagulants, Double-Blind Method, Drug Administration Schedule, Enoxaparin, Female, Hemorrhage, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Pulmonary Embolism, Venous Thromboembolism, Warfarin",
author = "B{\"u}ller, {Harry R} and Herv{\'e} D{\'e}cousus and Grosso, {Michael A} and Michele Mercuri and Saskia Middeldorp and Prins, {Martin H} and Raskob, {Gary E} and Schellong, {Sebastian M} and Lee Schwocho and Annelise Segers and Minggao Shi and Peter Verhamme and Phil Wells and {Hokusai-VTE Investigators} and Jeppesen, {J{\o}rgen Lykke}",
year = "2013",
month = oct,
day = "10",
doi = "10.1056/NEJMoa1306638",
language = "English",
volume = "369",
pages = "1406--15",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachusetts Medical Society",
number = "15",
}